Eye Hospital, University Medical Centre Ljubljana, Grablovičeva 46, 1000 Ljubljana, Slovenia.
Eye Hospital, University Medical Centre Ljubljana, Grablovičeva 46, 1000 Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.
J Fr Ophtalmol. 2024 Oct;47(8):104232. doi: 10.1016/j.jfo.2024.104232. Epub 2024 Aug 29.
Pathogenic variants in the CEP290 gene may result in a broad spectrum of diseases, ranging from lethal neonatal syndromes to isolated retinopathy. A detailed review of the clinical spectrum with the incidence of affected extraocular systems has not yet been published. A review of published papers was carried out to provide a comprehensive report on systemic signs and symptoms associated with CEP290 ciliopathies and to explore the genotype-phenotype correlation. Genetic and clinical data were collected on patients with biallelic variants in the CEP290 gene and the extraocular tissues affected. Genotype-phenotype analysis was performed. Two hundred thirty-five patients were included in the analysis. The most frequently reported organs affected, after the eye, were the central nervous system (82.6%, 194/235), followed by the kidney (53.2%, 125/235), skeletal system (15.3% 36/235), and a large spectrum of other, less frequently reported clinical manifestations. Patients with two variants that together predictably resulted in a low amount of CEP290 protein showed a significant association with having two or more extraocular organ systems affected. This is the most extensive report to date on patients with CEP290-ciliopathy and affected extraocular tissues. Based on these findings and previous publications, systemic screening is proposed, together with a clinical pathway for patients with CEP290-related ciliopathy.
CEP290 基因中的致病变异可导致广泛的疾病谱,从致死性新生儿综合征到孤立性视网膜病变。尚未发表对伴有眼外系统受累的 CEP290 纤毛病的临床谱及其发病率进行详细综述。我们对已发表的文献进行了综述,旨在提供一份关于与 CEP290 纤毛病相关的系统性体征和症状的综合报告,并探讨基因型-表型相关性。对 CEP290 基因双等位变异的患者及其受影响的眼外组织收集了遗传和临床数据,并进行了基因型-表型分析。共有 235 例患者纳入分析。除眼部以外,最常报道的受累器官依次为中枢神经系统(82.6%,194/235)、肾脏(53.2%,125/235)、骨骼系统(15.3%,36/235),以及一系列其他较少报道的临床表现。同时携带两种可预测导致 CEP290 蛋白量减少的变异的患者,其具有两个或更多眼外器官系统受累的显著相关性。这是迄今为止关于 CEP290 纤毛病和受影响眼外组织患者的最广泛报告。基于这些发现和以前的出版物,我们建议对 CEP290 相关纤毛病患者进行系统性筛查,并制定临床路径。